dhplc-grade wave optimized buffer a (Transgenomic)
90
Structured Review
Transgenomic
dhplc-grade wave optimized buffer a
Dhplc Grade Wave Optimized Buffer A, supplied by Transgenomic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dhplc-grade+wave+optimized+buffer+a/wave+optimized+buffer+a/pm19778530-62-3-13
Average 90 stars, based on 1 article reviews
Dhplc Grade Wave Optimized Buffer A, supplied by Transgenomic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dhplc-grade+wave+optimized+buffer+a/wave+optimized+buffer+a/pm19778530-62-3-13
Average 90 stars, based on 1 article reviews
dhplc-grade wave optimized buffer a - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Polymerase Chain Reaction:Article Title: Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: Involvement in tumor progression and metastasis Article Snippet: .. The mobile phase used 0.1 M triethylammonium acetate (TEAA) solution in water, pH 7.0 ( Article Title: Improving sensitivity of electrophoretic heteroduplex analysis using nucleosides as additives: Application to the breast cancer predisposition gene BRCA2. Article Snippet: A new method for the detection of unknown mutations, enhanced mismatch mutation analysis (EMMA), is proposed.. It is based on electrophoretic heteroduplex analysis (HDA).. The resolution is considerably improved, thanks to the combination of highresolution block-copolymer sieving matrix, and nucleosides as additives in the electrophoretic medium. Article Title: A novel P755L mutation in LRRK2 gene associated with Parkinson's disease Article Snippet: Parkinson’s disease is a common neurodegenerative disorder.. The identi¢cation of leucine-rich repeat kinase 2 (LRRK2) gene mutations as a cause of Parkinson’s disease has greatly expanded our knowledge of the genetic and molecular pathogenesis of this disorder.. By denaturing high-performance liquid chromatography and gene sequencing in patients and controls, we identi¢ed a novel frequent heterozygous 2264C-T substitution, which causes a proline-to-leucinemutation (P755L) in LRRK2 gene. Article Title: Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Article Snippet: C. Houdayer, M. Gauthier-Villars, A. Laugé, S. Pagès-Berhouet, C. Dehainault, V. Caux-Moncoutier, P. Karczynski, M. Tosi, F. Doz, L. Desjardins, J. Couturier, and D. Stoppa-Lyonnet Service de Génétique Oncologique, Institut Curie, Paris, France; INSERM EMI 9906, IFRMP, Faculté de Médecine et Pharmacie, Rouen, France; Service d’Oncologie Pédiatrique, Institut Curie, Paris, France; Service d’Ophtalmologie, Institut Curie, Paris, France; INSERM U509, Pathologie Moléculaire des Cancers, Institut Curie, Paris, France other:Article Title: A high-throughput mutation detection method based on heteroduplex analysis using graft copolymer matrixes: application to Brca1 and Brca2 analysis. Article Snippet: We present here a new approach to electrophoretic heteroduplex analysis (EHDA) based on improved matrixes.. EHDA is an appealing technique for the detection of unknown point mutations because of its simplicity and high throughput.. We present here a new matrix for electrophoretic heteroduplex analysis much more sensitive for insertions, deletions, and substitutions than reported for previous EHDA separations and also superior to DHPLC. Article Title: Application of the DHPLC method for mutational detection of the CYP21A2 gene in congenital adrenal hyperplasia. Article Snippet: a Department of Pediatrics and Buddhist Tzu Chi General Hospital, Taipei Branch, 289 Jianguo Road, Sindian City, Taipei County 231, Taiwan b Graduate Institute of Pharmacology and Toxicology, College of Medicine, Tzu Chi University, 701 Chung Yang Road, Sec. 3, Hualien City, Hualien 970, Taiwan c Institute of Biomedical Science, Academia Sinica, Nankang, Taipei 115, Taiwan d Molecular Medicine Research Center, Chang Gung University, Taoyuan 330, Taiwan e Medical Research, Buddhist Tzu Chi General Hospital, Taipei Branch, 289 Jianguo Road, Sindian City, Taipei County 231, Taiwan f School of Chinese Medicine, College of Chinese Medicine, China Medical University, 91 Hsueh-Shih Road, Taichung 404, Taiwan Article Title: KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography Article Snippet: The Kirsten Rat Sarcoma (KRAS) oncogene has been introduced recently as a genetic biomarker for metastatic sporadic colorectal cancer prior to anti-EGFR treatment.. Identifying patients with KRAS mutations that not respond to EGFR targeted therapies require sensitive, rapid and efficacious routine technique.. We have attempted to evaluate the efficiency of three conventional methods: direct sequencing, HRM and DHPLC, to detect mutations in codon 12 and 13 of the KRAS exon2 gene. |